These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 35841083)

  • 1. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
    Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients.
    Pitiriga V; Bakalis J; Theodoridou K; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Nov; 11(1):137. PubMed ID: 36352414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central venous catheter-related bloodstream infection and colonization: the impact of insertion site and distribution of multidrug-resistant pathogens.
    Pitiriga V; Kanellopoulos P; Bakalis I; Kampos E; Sagris I; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2020 Dec; 9(1):189. PubMed ID: 33261661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of microbial colonization rates between central venous catheters and peripherally inserted central catheters.
    Pitiriga V; Bakalis J; Theodoridou K; Dimitroulia E; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2023 Aug; 12(1):74. PubMed ID: 37550791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Risk Factors of Long-term Central Venous Catheter-associated Bloodstream Infections in Children.
    Moon HM; Kim S; Yun KW; Kim HY; Jung SE; Choi EH; Lee HJ
    Pediatr Infect Dis J; 2018 May; 37(5):401-406. PubMed ID: 29194165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Rates of Central Line-Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters.
    Dube WC; Jacob JT; Zheng Z; Huang Y; Robichaux C; Steinberg JP; Fridkin SK
    JAMA Netw Open; 2020 Mar; 3(3):e200396. PubMed ID: 32129868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripherally inserted central catheters have a protective role and the effect of fluctuation curve feature in the risk of bloodstream infection compared with central venous catheters: a propensity-adjusted analysis.
    Lv Y; Huang X; Lan Y; Xia Q; Chen F; Wu J; Li W; Cao H; Xie C; Li L; Han H; Wang H; Xiang Q
    BMC Infect Dis; 2022 Mar; 22(1):289. PubMed ID: 35346073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central-Line-Associated Bloodstream Infections (CLABSIs) Incidence and the Role of Obesity: A Prospective, Observational Study in Greece.
    Tsolakoglou I; Intas G; Stergiannis P; Sakkou A; Chalari E; Tsoumakas K; Elefsiniotis I; Fildissis G
    Adv Exp Med Biol; 2020; 1196():11-18. PubMed ID: 32468303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the multimodal intervention including an automatic notification of catheter days on reducing central line-related bloodstream infection: a retrospective, observational, quasi-experimental study.
    Bae S; Kim Y; Chang HH; Kim S; Kim HJ; Jeon H; Cho J; Lee J; Chae H; Han G; Kim SW
    BMC Infect Dis; 2022 Jul; 22(1):604. PubMed ID: 35804323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Line days as a determinant of central line-associated bloodstream infections in pediatric patients with tunneled femoral peripherally inserted central catheters.
    Koo KSH; Cooper AB; Monroe EJ; Reis J; Shivaram GM; Zerr DM
    Pediatr Radiol; 2021 Jul; 51(8):1481-1486. PubMed ID: 33675377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of central venous catheter insertion and care bundles in a high central line-associated bloodstream infection rate, high bed occupancy hospital.
    Karapanou A; Vieru AM; Sampanis MA; Pantazatou A; Deliolanis I; Daikos GL; Samarkos M
    Am J Infect Control; 2020 Jul; 48(7):770-776. PubMed ID: 31911066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
    Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
    Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of enterococcal central line-associated bloodstream infections in patients with cancer.
    Awadh H; Chaftari AM; Khalil M; Fares J; Jiang Y; Deeba R; Ali S; Hachem R; Raad II
    BMC Infect Dis; 2021 Jul; 21(1):643. PubMed ID: 34225651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
    Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
    Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
    Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.